The object of this study was to Investigate the beta-adrenergic receptor binding affinity of 4-acylaminophenoxypropanolamine (10-15) and 5-acylaminonaphthyloxypropanolamine (21-24) derivatives, which were prepared from 4-aminophenol (5) and 5-amino-1-naphthol (16), respectively. The in vitro beta(1)- and beta(2)-adrenergic receptor binding affinities of the newly synthesized compounds were assessed in turkey erythrocyte membrane (beta(1)) and lung homogenates of rats (beta(2)). The binding affinities were compared with that of propranolol (3) (propranolol hydrochloride, CAS 318-98-9). The compound N-[5-(3-tert-butylamino-2-hydroxy-propoxy)-naphthalen-1-yl]- acetamide (22) has beta-adrenergic receptor affinity comparable with that of propranolol and shows selectivity to beta(1)-adrenergic receptors

Jindal, D.P., Coumar, M.S., Bruni, G., & Massarelli, P. (2002). Synthesis and beta1-, beta2-adrenergic receptor binding studies of 4-acylamino substituted phenoxypropanolamine and 5-acylamino substituted naphthyloxypropanolamine derivatives. ARZNEIMITTEL-FORSCHUNG, 52(9), 654-663.

Synthesis and beta1-, beta2-adrenergic receptor binding studies of 4-acylamino substituted phenoxypropanolamine and 5-acylamino substituted naphthyloxypropanolamine derivatives

BRUNI, GIANCARLO;MASSARELLI, PAOLA
2002

Abstract

The object of this study was to Investigate the beta-adrenergic receptor binding affinity of 4-acylaminophenoxypropanolamine (10-15) and 5-acylaminonaphthyloxypropanolamine (21-24) derivatives, which were prepared from 4-aminophenol (5) and 5-amino-1-naphthol (16), respectively. The in vitro beta(1)- and beta(2)-adrenergic receptor binding affinities of the newly synthesized compounds were assessed in turkey erythrocyte membrane (beta(1)) and lung homogenates of rats (beta(2)). The binding affinities were compared with that of propranolol (3) (propranolol hydrochloride, CAS 318-98-9). The compound N-[5-(3-tert-butylamino-2-hydroxy-propoxy)-naphthalen-1-yl]- acetamide (22) has beta-adrenergic receptor affinity comparable with that of propranolol and shows selectivity to beta(1)-adrenergic receptors
File in questo prodotto:
File Dimensione Formato  
Arzneim.Forsch 2002, 654-663.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 3.11 MB
Formato Adobe PDF
3.11 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/8221
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo